Midlife Intakes of the Isoflavone Genistein and Soy and the Risk of Late-life Cognitive Impairment: The JPHC Saku Mental Health Study
- PMID: 34924453
- PMCID: PMC10257986
- DOI: 10.2188/jea.JE20210199
Midlife Intakes of the Isoflavone Genistein and Soy and the Risk of Late-life Cognitive Impairment: The JPHC Saku Mental Health Study
Abstract
Background: The number of people with cognitive impairment, including dementia, in the world is steadily increasing. Although the consumption of isoflavones and soy is associated with a reduced risk of cardiovascular disease, it might also be associated with cognitive impairment. The low number of studies investigating the association between soy/isoflavone intake and cognitive function warrant additional research.
Methods: The Japan Public Health Center-based prospective (JPHC) Study is a large population-based cohort. Midlife dietary intake of soy and the isoflavone genistein was assessed on two occasions: in the years 1995 and 2000. In 2014-2015, 1,299 participants from Nagano prefecture completed a mental health screening. Of these, a total of 1,036 participants were included in analyses. Logistic regression was used to determine Odds Ratios (OR) and 95% Confidence Intervals (CI) for the association between midlife energy-adjusted genistein and soy food intake and cognitive impairment.
Results: There were 392 cases of cognitive impairment (346 cases of MCI and 46 cases of dementia). Compared to the lowest dietary quartile of energy-adjusted genistein intake, the highest quartile was significantly associated with cognitive impairment (OR = 1.51; 95% CI, 1.02-2.24; P for trend = 0.03) in the final multivariable analysis.
Conclusion: High midlife intake of the isoflavone genistein is associated with late-life cognitive impairment.
Keywords: dementia; general population cohort; isoflavones; late-life; midlife; mild cognitive impairment; soy foods.
Conflict of interest statement
Conflicts of interest: TS, NS, SN, RS, and ST declare no conflicts of interest. MM declares having received grants from Daiichi Sankyo, Eisai, Pfizer, Shionogi, Takeda, Tanabe Mitsubishi and Tsumura, and payment or honoraria from Byer Pharmaceutical, Daiichi Sankyo, Dainippon-Sumitomo Pharma, Eisai, Eli Lilly, Fuji Film RI Pharma, Hisamitsu Pharmaceutical, Janssen Pharmaceutical, Kyowa Pharmaceutical, Mochida Pharmaceutical, MSD, Mylan EPD, Nihon Medi-physics, Nippon Chemipher, Novartis Pharma, Ono Yakuhin, Otsuka Pharmaceutical, Pfizer, Santen Pharmaceutical, Shire Japan, Takeda Yakuhin, Tsumura, and Yoshitomi Yakuhin.
Figures
Similar articles
-
Soy isoflavone intake is associated with risk of Kawasaki disease.Nutr Res. 2016 Aug;36(8):827-34. doi: 10.1016/j.nutres.2016.04.002. Epub 2016 Apr 12. Nutr Res. 2016. PMID: 27440537 Free PMC article.
-
Dairy, soy, and calcium consumption and risk of cognitive impairment: the Singapore Chinese Health Study.Eur J Nutr. 2020 Jun;59(4):1541-1552. doi: 10.1007/s00394-019-02010-8. Epub 2019 Jun 3. Eur J Nutr. 2020. PMID: 31161350 Free PMC article.
-
Soy product intake and risk of incident disabling dementia: the JPHC Disabling Dementia Study.Eur J Nutr. 2022 Dec;61(8):4045-4057. doi: 10.1007/s00394-022-02937-5. Epub 2022 Jul 5. Eur J Nutr. 2022. PMID: 35788776 Free PMC article.
-
High soy isoflavone or soy-based food intake during infancy and in adulthood is associated with an increased risk of uterine fibroids in premenopausal women: a meta-analysis.Nutr Res. 2019 Nov;71:30-42. doi: 10.1016/j.nutres.2019.06.002. Epub 2019 Jun 8. Nutr Res. 2019. PMID: 31668644 Review.
-
Soy and isoflavone consumption and risk of gastrointestinal cancer: a systematic review and meta-analysis.Eur J Nutr. 2016 Feb;55(1):63-73. doi: 10.1007/s00394-014-0824-7. Epub 2014 Dec 30. Eur J Nutr. 2016. PMID: 25547973 Review.
Cited by
-
Nutrition and Healthy Ageing in Asia: A Systematic Review.Nutrients. 2023 Jul 14;15(14):3153. doi: 10.3390/nu15143153. Nutrients. 2023. PMID: 37513571 Free PMC article. Review.
-
The health effects of soy: A reference guide for health professionals.Front Nutr. 2022 Aug 11;9:970364. doi: 10.3389/fnut.2022.970364. eCollection 2022. Front Nutr. 2022. PMID: 36034914 Free PMC article. Review.
References
-
- Prince M, Wimo A, Guerchet M, Ali GC, Wu Y, AM. P. World Alzheimer Report 2015: The global impact of dementia. An analysis of prevalence, incidence, costs and trends. London: Alzheimer’s Disease International; 2015.
-
- Kokubo Y, Iso H, Ishihara J, Okada K, Inoue M, Tsugane S; JPHC Study Group . Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation. 2007;116:2553–2562. 10.1161/CIRCULATIONAHA.106.683755 - DOI - PubMed